as well as resident and fellow surgical assistance were documented. Patient and female partner age, natural pregnancy rates, procedure type, pre-and post-operative semen parameters, time from vasectomy, and postoperative complications were all evaluated. The effects of a fellow surgical assistance on perioperative and postoperative outcomes were then analyzed. Statistical significance, defined as a p-value <0.05, was determined using Student's T, chi square or Fischer exact test.
as well as resident and fellow surgical assistance were documented. Patient and female partner age, natural pregnancy rates, procedure type, pre-and post-operative semen parameters, time from vasectomy, and postoperative complications were all evaluated. The effects of a fellow surgical assistance on perioperative and postoperative outcomes were then analyzed. Statistical significance, defined as a p-value <0.05, was determined using Student's T, chi square or Fischer exact test. RESULTS: We identified 183 patients who underwent subinguinal varicocele ligation or vasectomy reversal by a single surgeon at our institution. All patients undergoing surgery for fertility concerns were included for analysis. Vasectomy reversals requiring one or more vasoepididymostomy were excluded from analysis, due to insufficient numbers for meaningful comparison, as were any patients undergoing combined cases in addition to microsurgical surgery. Compared to when faculty was operating without a fellow (n¼72), fellow surgical assistance (n¼81) results in a statistically significant prolonged operative time for both unilateral varicocele ligation (1:22 vs 1:01, p<0.01), bilateral varicocele ligation (2:13 vs 1:43, p<0.01), and bilateral vasovasostomy (2:49 vs 2:19, p<0.01). Comparing fellow assisted cases to those without a fellow, there were no significant differences in all other outcome measurements or patient demographics. Overall, 69.0% of patients undergoing varicocelectomy experienced a significant improvement in their Total Motile Sperm Count post-operatively, and 100% of patients achieved patency after vasectomy reversal.
CONCLUSIONS: Fellowship training was associated with ã 30% increase in operative time for unilateral and bilateral varicocele ligation, and a~20% increase in operative time for bilateral vasovasostomy, but does not adversely impact outcomes of microsurgical cases.
Source of Funding: None

MP89-19 TIMING OF RETURN OF SPERM TO THE EJACULATE AND LATE FAILURES FOLLOWING VASAL RECONSTRUCTION
Ryan Flannigan*, New York , NY; Phil V. Bach, New York, NY; Abimbola Ayangbesan, Andrew Gottesdiener, Marc Goldstein, New York , NY INTRODUCTION AND OBJECTIVES: Vasal reconstruction is an effective method of treating obstructive azoospermia, with reported patency rates of 99% for vasovasostomy (VV) and 80% for vasoepididymostomy (VE). When deciding between sperm retrieval with in vitro fertilization or vasal reconstruction, a major consideration is often the length of time it will take for sperm to return to the ejaculate following vasal reconstruction. The objective of this study was to compare the time required for sperm to return to the ejaculate following VV or VE, and if the rate of late failures would be less common in VV compared to VE.
METHODS: We performed a retrospective review of all patients undergoing VV and VE by a single surgeon. Demographic information, surgical details, and postoperative semen analysis (SA) values and dates were reviewed. Late failures were defined as those with sperm return to the ejaculate post-reconstruction who subsequently became azoospermic. Descriptive statistics, student t-test, and Fishers exact tests were used to compare the groups, with significance set at p<0.05.
RESULTS: 338 and 37 men underwent VV and VE, respectively, and had sperm return to the ejaculate postoperatively. Mean age was 43+/-6.7 years, with a mean obstructive period of 10+/-5.5 years. Mean time to return of sperm in the ejaculate was faster following VV than after VE (Table 1) . Initial sperm counts were also higher following VV compared to VE (Table 1) . Longitudinally, more men had late failure of vasal reconstruction after VE than after VV (Table 1) . Presence of sperm granuloma did not impact time to return of sperm in the ejaculate (p¼0.22) after VV. Obstructive interval was not associated with either sperm count in the ejaculate after vasal reconstruction or time to return of sperm to the ejaculate. CONCLUSIONS: Among men undergoing vasal reconstruction, return of sperm to the ejaculate typically occurs at 3 months after VV and at 5 months after VE. A small, but significant, proportion of men undergoing vasal reconstruction will have late failures, especially after VE. Since these late failures typically occur within one year postoperatively, men undergoing vasal reconstruction should be advised to consider sperm cryopreservation as soon as motile sperm appear in the ejaculate. 
Source of Funding: Frederick J and Theresa Dow Wallace
INTRODUCTION AND OBJECTIVES:
Microsurgical denervation of the spermatic cord (MDSC) is a treatment option for chronic scrotal content pain that is unresponsive to conservative treatments. A recent study has shown specific nerve fiber abnormalities (Wallerian degeneration) in the cord as a potential cause for this pain. Our goal was to assess outcomes of a more targeted technique in ablating only these abnormal nerves when performing MDSC: targeted robotic assisted microsurgical denervation of the spermatic cord (RMDSC).
METHODS: Retrospective review of 772 patients who underwent RMDSC by two fellowship trained microsurgeons from October 2008 to July 2016. Selection criteria were as follows: chronic testicular pain (>3 months), failed standard pain management treatments and negative urologic workup. Targeted ligation of tissues containing the trifecta location of nerves with Wallerian degeneration was performed: the cremasteric muscle fibers, the peri-vasal sheath and the posterior spermatic cord lipomatous tissues. The primary outcome measure was level of pain. Pain was assessed preoperatively and postoperatively using two assessment tools: a) the subjective visual analog scale (VAS) and b) an objective standardized externally validated pain assessment tool (PIQ-6, QualityMetric Inc., Lincoln, RI).
RESULTS: Median age was 41 years. Median operative duration (robot console time) was 20 minutes (15-80). Median follow up was 24 months. Subjective VAS patient pain outcomes: 84% significant reduction in pain (50% complete resolution e 425 patients, 34% reported a greater than 50% reduction in pain e 291 patients). Objective PIQ-6 outcomes: significant reduction in pain in 67% of patients at 6 months and 68% at 1 year post-op.
CONCLUSIONS: Targeted robotic assisted microsurgical denervation of the spermatic cord is a safe and viable treatment option for patients with chronic scrotal content pain refractory to conservative measures. Further studies are warranted. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1209
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